Article 5 (Source: Trends in Food Science and Technology, 2020)
Due to the imminent danger presented by the rapidly spreading COVID-19, viable
prophylactic and therapeutic measures which can be deveioped and applied at the level
of the general public are being sought after. This urgent requirement for a solution are
reflected on the individual level by an unprecedcnted rise in consumer sales of
supplementary nutrients, nutraceutical products and functional foods which were
considered to be effective against intluenza and SARS virus, have been on the front
burner during this pandemic.
Such findings are consistent with Google and Tastewise research which
demonstrated there is rising trend for vitamin C, D, zinc, elderberry, rosemary.
echinacea, melatonin, phospbatidylserine, collagen, and mushrooms. Although,
consumers are seeking to use any functional food that is used self-nedicating theit
moods. As data from in vitro studies accumulates, several viable mechanistic targets
for combatting COVID-19 are evident. These include those targeting specific elements
of the SARS-CoV-2 genome, including the spike protein (S), the RNA-dependent RNA
polymerase, the membrane protein (M), the envelope protein
(E), the NTPase/helicase.
required for virus budding and SARS-CoV main protease (3CL protease) are gaining
popularity to prevent the entrance of CoV into the cells of the hurnan body.
Whilst it was initially thought that children were not as susceptible to infection
with virulent strains COVID-19, SARS-CoV-2 infection in neonates, infants and
children have been reported. The first report of COVID-19 infection in children came
from the USA and comprised of a sample of infants and children aged between 2 months
and 15 years. Following this, this first incidence of child mortality resulting from
COVID-19 came from Iran's North Khorasan province, on March 24, 2020. This
received significant attention from global media and heightened interest in the relatively
cost-effective and realistic solutions being suggested in the field of pediatric nutrition.
In this connection, breastfeeding represents an important prophylactic agent against a
host of communicable and non-communicable diseases, and also has well-cstablished
therapeutic effects. This message has been clearly communicated by the media and
breastfeeding has subsequently been reported to be significantly more popular amongst
mothers than in previous years. It is well-known that breastmilk transmits antibodies
from the mother and that this confers enhanced immunity against likely microbial
exposures to the newly bomn infant. It has recently been shown that secretory
immunoglobulin A which constitutes 90% of the immunoglobulins content in
breastmilk, plays an important role in the immune response against COVID-19. The
importance ce so secretory immunoglobulin A has also been demonstrated in other viral
infections, such as infection with the rotavirus; the human immuno-deficiency virus
(HIV), the norovirus, the herpes simplex viruses, echoviruses 6 and 9, and polioviruses
1,2 and 3. Finally, there is data to suggest that the risk of viral infection with COVID
19 in infants changes according to the duration of breastfeeding episodes. Short
episodes appear to represent a negative independent risk factor for infection and it is in
this connection that WHO have issued guidelines for breastfeeding at home and in a
hospital setting.